New approaches to the treatment of osteoporosis
- 25 July 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 4 (4), 383-393
- https://doi.org/10.1016/s1367-5931(00)00109-5
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Lasofoxifene (CP-336,156), a Selective Estrogen Receptor Modulator, Prevents Bone Loss Induced by Aging and Orchidectomy in the Adult RatEndocrinology, 2000
- Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of OsteoporosisEndocrine Reviews, 2000
- Functional Oxytocin Receptors Discovered In Human OsteoblastsEndocrinology, 1999
- Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetatePublished by Wolters Kluwer Health ,1999
- A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone lossPublished by Wolters Kluwer Health ,1999
- Alternatives to the Use of Estrogen in Postmenopausal WomenEndocrine Reviews, 1999
- Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand FamiliesEndocrine Reviews, 1999
- A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal womenBone, 1999
- Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte developmentPublished by Wiley ,1999
- The Bone-Building Action of the Parathyroid HormoneDrugs & Aging, 1999